{"schema_version":"secwatch.filing_event.v1","accession":"0001096906-22-000092","form_type":"8-K","ticker":"AXIM","cik":"0001514946","company_name":"AXIM BIOTECHNOLOGIES, INC.","filed_at":"2022-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.815272+00:00","generated_at":"2026-06-27T18:36:58.332312+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"AXIM appoints Blake N. Schroeder as director to fill vacancy, effective Jan 6, 2022","bullets":["Schroeder replaces Mauricio Javier Gatto-Bellora, appointed by written consent of Series C preferred stockholder.","Schroeder serves as CEO and Chairman of Medical Marijuana, Inc., which holds ~16.4% of AXIM common stock.","He formerly served as COO of Forevergreen International and held roles at MonaVie; holds a J.D. and B.S. in Finance.","No related-party transactions or arrangements exist between Schroeder and AXIM."],"urls":{"canonical":"https://secwatch.observer/filing/0001096906-22-000092","json":"https://secwatch.observer/filing/0001096906-22-000092.json","markdown":"https://secwatch.observer/filing/0001096906-22-000092.md","text":"https://secwatch.observer/filing/0001096906-22-000092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/0001096906-22-000092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/axim-20220106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T18:36:58.332312+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"69d1b59d4f","claim":"Mauricio Javier Gatto-Bellora resigned as Director at AXIM BIOTECHNOLOGIES, INC..","evidence_excerpt":"consented by written consent in lieu of a meeting appointing Blake N. Schroeder to fill the director seat vacated by the resignation of Mauricio Javier Gatto-Bellora.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/0001096906-22-000092-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7802e465ba","claim":"Blake N. Schroeder was appointed as Director at AXIM BIOTECHNOLOGIES, INC..","evidence_excerpt":"consented by written consent in lieu of a meeting appointing Blake N. Schroeder to fill the director seat vacated by the resignation of Mauricio Javier Gatto-Bellora.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/0001096906-22-000092-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}